Table 4.

Mean medication days for patients pre- and post-CDSS, with and without AKI

MedicationNo AKI, n=82,474AKI, n=15,229
Pre-CDSS, n=29,367Post-CDSS, n=53,107P ValuePre-CDSS, n=4655Post-CDSS, n=10,574P Value
ACEI/ARB1.34±3.851.25±3.60<0.0012.20±7.332.18±7.040.38
NSAID1.82±4.681.86±4.75<0.014.55±9.524.83±10.130.01
Aminoglycoside0.22±2.340.20±2.420.050.84±5.980.82±5.970.26
Contrasta0.30±1.290.21±1.04<0.0010.55±1.950.30±1.47<0.001
Vancomycin1.23±4.341.31±4.48<0.0014.56±10.384.58±10.410.47
  • ACEI/ARB, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers; NSAID, nonsteroidal anti-inflammatory drugs.

  • a Excludes patients receiving more than 12 contrast exposures in a single admission.